Jonathan D. Glass received his undergraduate degree from Middlebury College (Vermont) and his MD from the University of Vermont. He trained in Neurology and Neuropathology at Johns Hopkins Hospital in Baltimore, where he was a faculty member until being recruited to Emory University in 1996. He is widely known for his research on the pathogenesis and prevention of nerve degeneration in neurological diseases, and for his work in human and experimental neuropathology. His laboratory focuses on the study of ALS and other neurodegenerative diseases using animal models, cell cultures, and human tissues to investigate the causes and potential cures for ALS, and clinically he is a leader in discovery projects on biomarkers and genetics of ALS. He has published >175 research paper in peer-reviewed journals. Dr. Glass is Director of the Emory ALS Center, which has grown to be one of the largest clinical centers in the Southeastern United States. Dr. Glass led the recent “first-in-human” clinical trial of spinal cord stem cell transplantation for ALS, which was a groundbreaking effort that set the standard for similar trials around the world. His leadership in promoting new efforts in ALS therapeutics is exemplified by his current position as co-Chair of the Northeast ALS Consortium (NEALS), an organization dedicated to advancing clinical research for ALS patients and their families.
Dr. Glass is an active clinician who has been cited each year since 2001 as one of "America's Top Doctors" (Castle Connelly) and since 2005 as one of "Atlanta's Top Doctors" (Atlanta Magazine). He is also a teacher and mentor to young physicians and served as the director of Emory's Neurology residency training program from 2001-2006.